Brookfield Corp’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-45,000
Closed -$8.66M 563
2023
Q2
$8.66M Buy
45,000
+40,000
+800% +$7.95M 0.03% 180
2023
Q1
$1.01M Buy
+5,000
New +$802K ﹤0.01% 501
2022
Q3
Sell
-73,692
Closed -$13M 800
2022
Q2
$13M Buy
73,692
+17,965
+32% +$2.59M 0.06% 118
2022
Q1
$8.03M Buy
+55,727
New +$7.54M 0.03% 186

Other funds holding SGEN

Brookfield Corp's SGEN Position: Q3 2023 in Review

Brookfield Corp sold out of Seagen Inc. Common Stock (SGEN) in Q3 2023, closing a stake of 45,000 shares — an estimated $8.66M sold.

Brookfield Corp first reported a position in SGEN in Q1 2022 and held it in 4 quarters. The position peaked at $13M in Q2 2022. 616 funds tracked by Wall St. Rank hold SGEN as of Q3 2023.

  • Brookfield Corp reported no remaining Seagen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 45,000 Seagen Inc. Common Stock shares in Q3 2023, an estimated $8.66M.
  • Brookfield Corp first reported a position in Seagen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Brookfield Corp's Seagen Inc. Common Stock position peaked at $13M in Q2 2022.
  • 616 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.